|
Enhanced
Support Capability via the Internet |
|
Less than
3 weeks to go to the 2006 User Group |
|
Warfarin
increases the risk of bone fracture |
|
Likelihood of haemorrhage on warfarin
is relatively small |
|
The
Ethnic difference |
|
Less
expensive anti clotting medication |
Enhanced Support Capability via the
Internet
It is now possible for us to view your
system using the internet for support purposes. This helps greatly
with the diagnosis of your problem and it is relatively easy to set
up.
So before you need to make your next
support call, why not put this in place now? If you want to
do this please let us know.
Less than Three Weeks to go to the
2006 User Group!
Hopefully
you all received the July 2006 special edition of the Dawn AC
newsletter through the post, as this outlined the agenda for the
User Group talks. For those of you who have seen it will notice that
there are some great talks lined up, and a Steamer boat ride to
start the two days off, which will give those of you who have not
yet visited the Lake District a really beautiful insight to this
area of
England.
There is still time to get your
booking forms to us for those of you who can get the time off – just
fax the form through on +44 15395 62475.
To see the agenda please follow
this hyperlink:
http://www.4s-dawn.com/dawnac/usergroup2006.htm
Warfarin
Increases the Risk of Bone Fracture
Elderly
patients taking the commonly prescribed
Warfarin experience an increased risk for osteoporosis-linked
bone fractures. This is because vitamin K also interacts with
osteocalcin and
warfarin's antagonism of vitamin K has the potential to
affect bone strength as well.
Long-term use of Warfarin led to a 25
percent increase in the incidence of fracture. 80 percent of those
affected by osteoporosis are women but the women's risk of fracture
did not increase by a statistically meaningful amount on long-term
Warfarin therapy. However, men in the
study who took warfarin for more than a
year had a 63 percent higher incidence of fracture than men who did
not take the blood thinner.
Source:
Washington
University
School of
Medicine, 2006
To read the full article, follow this
hyperlink:
http://www.xagena.it/news/medicinenews_net_news/c4a215133d24223a0bb308787ac7b7f5.html
Study Finds Likelihood of
Haemorrhage on
Warfarin is Relatively Small
Older
patients with atrial fibrillation have
higher rates of major hemorrhage in the brain whether or not they
are using a common blood thinning therapy, according to a new study.
Prior studies
have shown that anticoagulation medication, such as
warfarin, substantially reduces the risk
of atrial fibrillation-related stroke,
but also increases the risk for hemorrhage.
The overall
likelihood of hemorrhage on warfarin is
relatively small, especially when one considers the benefits of
stroke prevention,"
The rates of
intracranial hemorrhage rose at age 80 and older, this link shows
that regardless of therapy, physicians should be especially vigilant
in monitoring patients over age 80 with atrial
fibrillation."
To read the full article, follow this
hyperlink:
http://www.ucsf.eduhttp://www.news-medical.net/?id=19193
The Ethnic Difference
Patients
need different dosages of the commonly-used anti-clotting drug -
warfarin - to achieve the same effect,
raising the possibility that medicine, in the future, could be
prescribed based on ethnicity. For example, Indians need about 60 to
70% more warfarin than their Chinese and
Malay counterparts.
It has been discovered that a gene decides as it is responsible for
recycling the body's Vitamin K, which is the target of
warfarin in the anti-clotting process.
The study found that there are variations in the makeup of the gene
in
different
races. This means that Indians need 6mg a day of
warfarin, compared to 3.5mg a day for
the Chinese.
To read the full article, follow this
hyperlink:
http://www.channelnewsasia.com/stories/health/view/227200/1/.html
Less
Expensive Anti-clotting Medication Appears as Safe and Effective as
More Expensive Treatment
 Subcutaneous
injection of the original and less expensive form of the
anticoagulant medication heparin is as effective and safe as
subcutaneous administration of the newer and more expensive
low-molecular-weight heparin for treatment of venous
thromboembolism. Find out more at (JAMA.
2006;296:991-993.)
To read the full article, follow this
hyperlink:
http://www.medicalnewstoday.com/medicalnews.php?newsid=50303
|